Due to the lack of any antiviral for a newly emergent virus, blood harvested from individuals who were infected by the virus and subsequently fully recovered without hospitalization is in a clinical trial to treat individuals who are very sick by the virus. The donors have been carefully screened to eliminate their possibility as carriers (in their blood) of any virus. Which of the followings is the best strategy for this clinical trial: generating sera from the donors' blood and injected them i.v. to the recipients whose blood types are matched to those of the donors matching blood type of the donors and recipients before blood transfusion generating sera from the donors' blood and injected them intravenously (i.v.) to the recipients without worrying about the matching of their blood types there are more than 1 correct answers in the other choices
Due to the lack of any antiviral for a newly emergent virus, blood harvested from individuals who were infected by the virus and subsequently fully recovered without hospitalization is in a clinical trial to treat individuals who are very sick by the virus. The donors have been carefully screened to eliminate their possibility as carriers (in their blood) of any virus. Which of the followings is the best strategy for this clinical trial:
generating sera from the donors' blood and injected them i.v. to the recipients whose blood types are matched to those of the donors |
||
matching blood type of the donors and recipients before blood transfusion |
||
generating sera from the donors' blood and injected them intravenously (i.v.) to the recipients without worrying about the matching of their blood types |
||
there are more than 1 correct answers in the other choices |

Step by step
Solved in 2 steps









